期刊文献+

纤维支气管镜下敏感抗生素肺泡灌洗对重症肺炎患儿血清MMP-9及TIMP-1水平的影响 被引量:28

Effect of bronchoalveolar lavage with sensitive antibiotics under fiber bronchoscope on serum level of MMP-9 and TIMP-1 in children with severe pneumonia
暂未订购
导出
摘要 目的:探讨纤维支气管镜下敏感抗生素肺泡灌洗对重症肺炎患儿血清基质金属蛋白酶-9(MMP-9)、基质金属蛋白酶抑制剂-1(TIMP-1)的表达及临床意义。方法:选取2017年7月至2019年1月广西医科大学第十附属医院收治的重症肺炎患儿60例,随机分为观察组和对照组,每组30例。对照组采用常规抗生素治疗方式,观察组在对照组基础上进行纤维支气管镜肺泡灌洗治疗。比较两组治疗前、后血清MMP-9、TIMP-1水平、痰检阳性率、肺功能及不良反应发生情况。结果:治疗后,观察组MMP-9、TIMP-1水平和MMP-9/TIMP-1比值分别为(137.51±38.42)ng/mL、(120.46±36.34)ng/mL和1.07±0.38,均显著低于对照组的(172.42±40.50)ng/mL、(139.52±38.32)ng/mL和1.32±0.42(均P<0.05);治疗后,观察组肺功能参数达峰时间比(TPTEF/TE)、达峰容积比(VPTEF/VE)和潮气量(VT)分别为(31.09±5.48)%、(30.21±6.87)%和(7.63±1.31)m L/kg,均明显高于对照组的(21.43±5.32)%、(22.27±6.54)%和(6.65±1.42)mL/kg(均P<0.05);观察组痰检阳性率为26.67%,显著低于对照组的46.67%(均P<0.05);观察组总有效率为93.33%,高于对照组的76.67%(P<0.05);两组均未出现严重的不良反应。结论:纤维支气管镜下敏感抗生素肺泡灌洗治疗重症肺炎患儿疗效显著,能够显著降低血清中MMP-9、TIMP-1水平,缓解炎症损伤,改善呼吸困难,具有较高的临床应用价值。 Objective: To investigate the expression and clinical significance of serum matrix metalloproteinase-9(MMP-9)and matrix metalloproteinase inhibitor-1(TIMP-1)in children with severe pneumonia after bronchoalveolar lavage with sensitive antibiotics under fiber bronchoscope.Methods: Sixty children with severe pneumonia who were admitted in the first people’s Hospital of Qinzhou from July 2017 to January 2019 were randomly divided into observation group and control group,with 30 cases in each group.Patients in the control group were treated with routine antibiotics,and patients in the observation group were treated with bronchoalveolar lavage with fiber bronchoscope on the basis of the control group.The levels of serum MMP-9 and TIMP-1,the positive rate of sputum examination,lung function,and adverse reactions were compared between the two groups before and after treatment.Results: After treatment,the levels of MMP-9,TIMP-1,and the ratio of MMP-9/TIMP-1 in the observation group were(137.51±38.42)ng/mL,(120.46±36.34)ng/mL and 1.07±0.38 respectively,which were significantly lower than those in the control group(172.42±40.50)ng/mL,(139.52±38.32)ng/mL and 1.32±0.42(all P<0.05).After treatment,the peak time ratio(TPTEF/TE),peak volume ratio(VPTEF/VE),and tidal volume(VT)of lung function parameters in the observation group were(31.09±5.48)%,(30.21±6.87)% and(7.63±1.31)mL/kg respectively,which were significantly higher than those in the control group(21.43±5.32)%,(22.27±6.54)% and(6.65±1.42)mL/kg,respectively(all P<0.05).The positive rate of sputum examination in the observation group was26.67%,which was significantly lower than that in the control group(46.67%)(all P<0.05).The total effective rate in the observation group was 93.33%,which was higher than that in the control group(76.67%)(P<0.05).There were no serious adverse reactions in both groups.Conclusion: Bronchoalveolar lavage with sensitive antibiotics under fiber bronchoscope is effective in the treatment of children with severe pneumonia,which can significantly reduce the levels of MMP-9 and TIMP-1 in serum,relieve inflammatory injury and improve dyspnea.It is worthy for clinical popularization.
作者 黄莹萱 丁敏才 敖超 Huang Yingxuan;Ding Mincai;Ao Chao(Department of pediatrics,The 10th Affiliated Hospital of Guangxi Medical University,Qinzhou 535000,China;Department of pediatrics,Qinzhou Maternal and Child Health Hospital,Qinzhou 535000,China)
出处 《广西医科大学学报》 CAS 2020年第4期746-750,共5页 Journal of Guangxi Medical University
关键词 纤维支气管镜下肺泡灌洗 重症肺炎 基质金属蛋白酶-9 基质金属蛋白酶抑制因子-1 alveolar lavage under fiber bronchoscopy severe pneumonia matrix metalloproteinase-9(MMP9) matrix metalloproteinase inhibitor-1(TIMP-1)
  • 相关文献

参考文献8

二级参考文献92

  • 1莫光洲.支气管肺泡灌洗术治疗老年重症肺炎合并呼吸衰竭的疗效[J].中国老年学杂志,2014,34(6):1465-1466. 被引量:15
  • 2罗彬,于湘友,姜华,尹微.纤维支气管镜吸痰联合肺泡灌洗在呼吸机相关性肺炎治疗中的应用[J].中国老年学杂志,2014,34(10):2656-2658. 被引量:69
  • 3沈定霞,罗燕萍,崔岩,赵莉萍,白立彦.分离产金属β-内酰胺酶的铜绿假单胞菌[J].中华医院感染学杂志,2004,14(1):86-88. 被引量:109
  • 4刘又宁,陈民钧,赵铁梅,王辉,王睿,刘庆锋,蔡柏蔷,曹彬,孙铁英,胡云建,修清玉,周新,丁星,杨岚,卓建生,唐英春,张扣兴,梁德荣,吕晓菊,李胜歧,刘勇,俞云松,魏泽庆,应可净,赵峰,陈萍,侯晓娜.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8. 被引量:792
  • 5GBZ70-2009,尘肺病诊断标准[S].
  • 6Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.
  • 7de Roux A,Marcos MA,Garcia E,et al.Viral community-acquired pneumonia in nonimmunocompromised adults.Chest,2004,125:1343-1351.
  • 8Ostrosky-Zeichner L,Alexander BD,Kett DH,et al.Multicenter clinical evaluation of the (1→3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.Clin Infect Dis,2005,41:654-659.
  • 9Food and Drug Administration,HHS.Class Ⅱ Special Controls Guidance Document:serological assays for the detection of betaglucan.Fed Reqist,2004,69:56934-56936.
  • 10Mandell LA,Marrie TJ,Grossman RF,et al.Canadian guidelines for the initial management of community-acquired pneumonia:an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society.The Canadian CommunityAcquired Pneumonia Working Group.Clin Infect Dis,2000,31:383-421.

共引文献3474

同被引文献295

引证文献28

二级引证文献123

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部